Double systemic cytokine release syndrome following sequential infusion of anti-cd22 and anti-cd19 chimeric antigen receptor t cells after autologous hematopoietic stem cell transplantation for a central diffuse large b-cell lymphoma patient: a case report and literature review

HIGHLIGHTS

• who: Jing Zheng and colleagues from the Guangzhou Medical University, China have published the research work: Double systemic cytokine release syndrome following sequential infusion of anti-CD22 and anti-CD19 chimeric antigen receptor T cells after autologous hematopoietic stem cell transplantation for a central diffuse large B-cell lymphoma patient: A case report and literature review, in the Journal: (JOURNAL)
• what: The authors report a case of a patient with secondary CNSL who developed double CRS after ASCT combined with anti-CD22 and anti-CD19 CAR-T_cell therapy.
• how: Wang T analyzed the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.